Back to Rankings

PFE

PfizerD
NYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
View Chart
+
Peers tracked
9
U.S. public peers
Grade Position
Below peers
vs peer average
PFE vs peer average
41/100
PFE vs. peer average (D vs. C)
Grade spread
B 1 · C 4 · D 3 · F 1
Graded peers loaded
Coverage
9 graded
100% of tracked

Peer overview

AMGN is the first available peer comparator.

Large-cap biopharma peer with a broad commercial base and pipeline; relevant for comparing post-LOE portfolio replacement and capital allocation discipline.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerAMGNAmgen
PFE
Pfizer
AMGN
Amgen
Grade
D
D
Momentum
14
37
Value
58
63
Sentiment
55
34
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive

Grade position vs AMGN

PFE / AMGN
Grade Position
Below peers
PFE vs. peer average (D vs. C)
41/100
Momentum
14
AMGN
Value
58
AMGN
Sentiment
55
PFE

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs PFE
1
AMGN
AMGN
D
40/100
Even
2
GILD
GILD
C
60/100
-1
3
REGN
REGN
C
60/100
-1
4
DHR
Danaher Corp Common
D
40/100
Even
5
BMY
Bristol-Myers Squibb Co Common
D
40/100
Even
AMGN is the first peer returned for this comparison set.